학술논문
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma
Document Type
Article
Author
Ward, Jeffrey P. ; Berrien-Elliott, Melissa M.; Gomez, Felicia; Luo, Jingqin; Becker-Hapak, Michelle; Cashen, Amanda F.; Wagner-Johnston, Nina D.; Maddocks, Kami; Mosior, Matthew; Foster, Mark; Krysiak, Kilannin; Schmidt, Alina; Skidmore, Zachary L.; Desai, Sweta; Watkins, Marcus P.; Fischer, Anne; Griffith, Malachi; Griffith, Obi L.; Fehniger, Todd A. ; Bartlett, Nancy L.
Source
In Blood 31 March 2022 139(13):1999-2010
Subject
Language
ISSN
0006-4971